138 related articles for article (PubMed ID: 15808492)
1. Synthesis and evaluation of potential inhibitors of eIF4E cap binding to 7-methyl GTP.
Ghosh P; Park C; Peterson MS; Bitterman PB; Polunovsky VA; Wagner CR
Bioorg Med Chem Lett; 2005 Apr; 15(8):2177-80. PubMed ID: 15808492
[TBL] [Abstract][Full Text] [Related]
2. A mutant of eukaryotic protein synthesis initiation factor eIF4E(K119A) has an increased binding affinity for both m7G cap analogues and eIF4G peptides.
Friedland DE; Wooten WN; LaVoy JE; Hagedorn CH; Goss DJ
Biochemistry; 2005 Mar; 44(11):4546-50. PubMed ID: 15766285
[TBL] [Abstract][Full Text] [Related]
3. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
[TBL] [Abstract][Full Text] [Related]
4. Crystallographic and mass spectrometric characterisation of eIF4E with N7-alkylated cap derivatives.
Brown CJ; McNae I; Fischer PM; Walkinshaw MD
J Mol Biol; 2007 Sep; 372(1):7-15. PubMed ID: 17631896
[TBL] [Abstract][Full Text] [Related]
5. Structural changes of eIF4E upon binding to the mRNA 5' monomethylguanosine and trimethylguanosine Cap.
Rutkowska-Wlodarczyk I; Stepinski J; Dadlez M; Darzynkiewicz E; Stolarski R; Niedzwiecka A
Biochemistry; 2008 Mar; 47(9):2710-20. PubMed ID: 18220364
[TBL] [Abstract][Full Text] [Related]
6. Thermodynamic analysis of mRNA cap binding by the human initiation factor eIF4E via free energy perturbations.
Guimarães CR; Kopecky DJ; Mihalic J; Shen S; Jeffries S; Thibault ST; Chen X; Walker N; Cardozo M
J Am Chem Soc; 2009 Dec; 131(50):18139-46. PubMed ID: 19924990
[TBL] [Abstract][Full Text] [Related]
7. Influence of electric charge variation at residues 209 and 159 on the interaction of eIF4E with the mRNA 5' terminus.
Zuberek J; Jemielity J; Jablonowska A; Stepinski J; Dadlez M; Stolarski R; Darzynkiewicz E
Biochemistry; 2004 May; 43(18):5370-9. PubMed ID: 15122903
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of influenza virus RNP interaction with RNA cap structures and comparison to human cap binding protein eIF4E.
Hooker L; Sully R; Handa B; Ono N; Koyano H; Klumpp K
Biochemistry; 2003 May; 42(20):6234-40. PubMed ID: 12755627
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamics of mRNA 5' cap binding by eukaryotic translation initiation factor eIF4E.
Niedzwiecka A; Darzynkiewicz E; Stolarski R
Biochemistry; 2004 Oct; 43(42):13305-17. PubMed ID: 15491137
[TBL] [Abstract][Full Text] [Related]
10. The potyviral virus genome-linked protein VPg forms a ternary complex with the eukaryotic initiation factors eIF4E and eIF4G and reduces eIF4E affinity for a mRNA cap analogue.
Michon T; Estevez Y; Walter J; German-Retana S; Le Gall O
FEBS J; 2006 Mar; 273(6):1312-22. PubMed ID: 16519694
[TBL] [Abstract][Full Text] [Related]
11. Phosphorothioate analogs of m7GTP are enzymatically stable inhibitors of cap-dependent translation.
Kowalska J; Lukaszewicz M; Zuberek J; Ziemniak M; Darzynkiewicz E; Jemielity J
Bioorg Med Chem Lett; 2009 Apr; 19(7):1921-5. PubMed ID: 19269171
[TBL] [Abstract][Full Text] [Related]
12. Biophysical approach to studies of cap-eIF4E interaction by synthetic cap analogs.
Niedzwiecka A; Stepinski J; Antosiewicz JM; Darzynkiewicz E; Stolarski R
Methods Enzymol; 2007; 430():209-45. PubMed ID: 17913640
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of anti-reverse cap analogs (ARCAs) and their applications in mRNA translation and stability.
Grudzien-Nogalska E; Stepinski J; Jemielity J; Zuberek J; Stolarski R; Rhoads RE; Darzynkiewicz E
Methods Enzymol; 2007; 431():203-27. PubMed ID: 17923237
[TBL] [Abstract][Full Text] [Related]
14. Synthetic dinucleotide mRNA cap analogs with tetraphosphate 5',5' bridge containing methylenebis(phosphonate) modification.
Rydzik AM; Lukaszewicz M; Zuberek J; Kowalska J; Darzynkiewicz ZM; Darzynkiewicz E; Jemielity J
Org Biomol Chem; 2009 Nov; 7(22):4763-76. PubMed ID: 19865714
[TBL] [Abstract][Full Text] [Related]
15. Weak binding affinity of human 4EHP for mRNA cap analogs.
Zuberek J; Kubacka D; Jablonowska A; Jemielity J; Stepinski J; Sonenberg N; Darzynkiewicz E
RNA; 2007 May; 13(5):691-7. PubMed ID: 17369309
[TBL] [Abstract][Full Text] [Related]
16. Structures of the human eIF4E homologous protein, h4EHP, in its m7GTP-bound and unliganded forms.
Rosettani P; Knapp S; Vismara MG; Rusconi L; Cameron AD
J Mol Biol; 2007 May; 368(3):691-705. PubMed ID: 17368478
[TBL] [Abstract][Full Text] [Related]
17. Poisson-Boltzmann model analysis of binding mRNA cap analogues to the translation initiation factor eIF4E.
Szklarczyk O; Zuberek J; Antosiewicz JM
Biophys Chem; 2009 Mar; 140(1-3):16-23. PubMed ID: 19056157
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human malaria parasite Plasmodium falciparum eIF4E homologue and mRNA 5' cap status.
Shaw PJ; Ponmee N; Karoonuthaisiri N; Kamchonwongpaisan S; Yuthavong Y
Mol Biochem Parasitol; 2007 Oct; 155(2):146-55. PubMed ID: 17692399
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities.
Topisirovic I; Ruiz-Gutierrez M; Borden KL
Cancer Res; 2004 Dec; 64(23):8639-42. PubMed ID: 15574771
[TBL] [Abstract][Full Text] [Related]
20. Interaction between yeast eukaryotic initiation factor eIF4E and mRNA 5' cap analogues differs from that for murine eIF4E.
Kiraga-Motoszko K; Stepinski J; Niedzwiecka A; Jemielity J; Wszelaka-Rylik M; Stolarski R; Zielenkiewicz W; Darzynkiewicz E
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1711-4. PubMed ID: 14565502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
